Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$28.9M
192M shares
52-week range
$0.15 – $1.28
1% from low
Exchange
XASE
CS
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. Its revenue is derived from five reportable segments: Central, Academy, School, Resorts, and Discontinued operations. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America.
www.geniusgroup.netNo one on the platform currently holds GNS.
No tracked institution reports a position in GNS as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-31 | $0.1000 | |
| 2025-11-28 | $0.1000 |
| Execution date | Ratio |
|---|---|
| 2024-08-16 | 1-for-10reverse |
No one on the platform has traded GNS yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$GNS Just relax Guys it will big jump sooner or later 🔥💯
View on StockTwits ↗$FRGT $GNS Both will big jump take some time only 🔥💯⏰
View on StockTwits ↗$GNS let’s have a life changing “to the good” day! Who’s with me!!! 🙏✝️💥👍💪
View on StockTwits ↗$GNS Firm Publicly identifiable current/recent market-manipulation civil cases Regulatory actions Citadel Securities At least 3 Multiple SEC enforcement actions over the years Anson Funds/Advisors At least 2 At least 2 SEC settlements
View on StockTwits ↗$GNS I can identify at least 3 current/recent civil cases alleging market manipulation: Genius Group v. Citadel Securities et al. — filed November 2025 in the Southern District of New York. Allegations include spoofing, naked short selling, and depressing Genius's stock price. Aron Reynolds / Genius Group investors v. Citadel Securities et al. — a second Genius-related class action, filed June 29, 2026 in the Southern District of Florida, again alleging spoofing and naked short selling. Northwest Biotherapeutics v. Canaccord Genuity et al. — ongoing securities litigation involving Citadel and other market makers, alleging repeated spoofing/manipulation of Northwest Biotherapeutics stock. Nano Dimension v. Anson Funds et al. — filed in 2023. Nano alleged that Anson and other hedge funds coordinated to manipulate Nano's stock price and acquire shares at depressed prices. Honig v. Anson Funds Management et al. — filed May 6, 2026 in federal court in Texas. It alleges a “short-and-distort”
View on StockTwits ↗$GNS $MMTLP $QS remember https://www.investing.com/news/company-news/genius-group-wins-icc-arbitration-against-lzg-international-93CH-4623316
View on StockTwits ↗$GNS they have taken 4.4 mill shares to short today ,should be a fun day ,get the beers out lol
View on StockTwits ↗$GNS we have heard your wishes and hear by cancel the 🏧 and will not consider a r/s. That is all…. DO IT ROGER!! DO IT DO IT DO IT!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.